|
|
||||||||
The Annals of Thoracic Surgery, Vol 26, 515-524, Copyright © 1978 by The Society of Thoracic Surgeons
DM Lolley, JF Ray 3d, WO Myers, G Sheldon and RD Sautter
In a prospective study, patients who had an ejection fraction of 40% or
more and who were undergoing elective coronary artery operation were
randomly divided into three groups that differed in the method of anaerobic
substrate enhancement during cardiopulmonary bypass. Group 1, the controls
(n = 157), received no additional glucose, insulin, and potassium solutions
and experienced immediate spontaneous defibrillation (10%), transmural
myocardial infarction (10.3%), malignant ventricular arrhythmias (26%), and
severe atrial arrhythmias (20%). Group 2 (n = 120) received a bolus of
hypertonic glucose, insulin, and potassium in the pump perfusate before
aortic cross- clamping. In this group, the rate of spontaneous
defibrillation was 41%, of transmural infarction, 8.3%, of malignant
ventricular arrhythmias, 31%, and of severe atrial arrhythmias, 19%. Group
3 (n = 114) had the aortic root continuously infused with glucose, insulin,
and potassium solution at 4 degrees C during aortic cross-clamping. This
group was significantly improved; the rate of spontaneous defibrillation
was 60%, there were no transmural myocardial infarctions and the incidence
of severe atrial arrhythmias was 6% and that of malignant ventricular
arrhythmias, 5%. It is proposed that the superior clinical results in Group
3 resulted from better myocardial preservation achieved by more efficient
means of providing continuous anaerobic substrate, coronary washout, and
elution of lactic acidosis, uniform global hypothermia, and direct
supplemental myocardial potassium in addition to mere cardioplegic effects.
ARTICLES
Reduction of intraoperative myocardial infarction by means of exogenous anaerobic substrate enhancement: prospective randomized study
This article has been cited by other articles:
![]() |
A. G. Pittas, R. D. Siegel, and J. Lau Insulin Therapy and In-Hospital Mortality in Critically Ill Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials JPEN J Parenter Enteral Nutr, March 1, 2006; 30(2): 164 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Pittas, R. D. Siegel, and J. Lau Insulin Therapy for Critically Ill Hospitalized Patients: A Meta-analysis of Randomized Controlled Trials Arch Intern Med, October 11, 2004; 164(18): 2005 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Doenst, W. Bothe, and F. Beyersdorf Therapy with insulin in cardiac surgery: controversies and possible solutions Ann. Thorac. Surg., February 1, 2003; 75(2): S721 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Dearani, T. C. Axford, M. A. Patel, N. A. Healey, P. T. Lavin, and S. F. Khuri Role of myocardial temperature measurement in monitoring the adequacy of myocardial protection during cardiac surgery Ann. Thorac. Surg., December 1, 2001; 72(6): S2235 - 2243. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M.F. Elwatidy, M. A. Fadalah, E. A. Bukhari, K. A. Aljubair, A. Syed, A. K. Ashmeg, and M. R. Alfagih Antegrade crystalloid cardioplegia vs antegrade/retrograde cold and tepid blood cardioplegia in CABG Ann. Thorac. Surg., August 1, 1999; 68(2): 447 - 453. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |